Delivery Order SPE2DB24D2003-SPE2DB25FXCT1
Award Date
10/10/24
Potential Completion Date
10/11/24
Potential Value
$60K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $34,014.52 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on September 10, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of prescription medications,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,828.74 firm-fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a September 11, 2024 ultimate completion date and does not utilize a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a $4,195.42 firm-fixed price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a completion date of August 1, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the federal government, including the military and veterans' healthcare programs. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,076.88 firm fixed-price contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of May 1, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly supporting the Department of Defense (DoD) and Veterans...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,052.00 to the Corporate Office Division of Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract is for the supply of the pharmaceutical product "MOUNJARO 15 MG/0.5 ML PEN 0.5ML" with a completion date of April 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of...
This federal contract award, valued at $25,995.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of September 10, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, was awarded this delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,269.99 to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies...
This federal contract award, valued at $6,502.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order for the supply of 4565890586 - MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm-fixed-price pricing type and an ultimate completion date of September 23, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been...
This federal contract award, valued at $5,049.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of July 12, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,777.10 Firm Fixed Price Delivery Order contract is for the provision of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...